Literature DB >> 7629995

[Correlation between the intercellular adhesion molecule (E-cadherin) and its associated protein (alpha-catenin) expression and metastasis in human digestive cancers].

H Shiozaki1, J Gofuku, M Inoue, S Tamura.   

Abstract

The immunostaining (ABC method) of E-cadherin and alpha-catenin were performed on 46 esophageal cancers, 67 gastric cancers, 100 colon cancers. E-cadherin and alpha-catenin expression was evaluated as preserved and reduced according to the proportion of positive cells, respectively. The reduction of alpha-catenin expression was more significantly related to lymph node metastasis than that of E-cadherin. Furthermore, the frequency of hematogenous liver metastasis in preserved E-cadherin expression and reduced alpha-catenin expression was significantly higher than that in another combination of E-cadherin and alpha-catenin expression, in gastric and colon cancer. The reduction of alpha-catenin expression was associated with declined intercellular adhesiveness, which occasionally was not accompanied by reduction of E-cadherin. Therefore, the expression of alpha-catenin might more sensitively indicated cell-cell adhesion, predicting tumor metastasis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629995

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  3 in total

Review 1.  Cell surface molecules and their prognostic values in assessing colorectal carcinomas.

Authors:  J Haier; M Nasralla; G L Nicolson
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  The expression of cadherin-catenin complex in association with the clinicopathologic features of early gastric cancer.

Authors:  C Xiangming; S Hokita; K Nuruki; H Toyoyama; G Tanabe; M Baba; S Takao; T Aikou
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

3.  E-cadherin expression as a prognostic factor in patients with ovarian cancer: a meta-analysis.

Authors:  Chencheng Dai; Jian Cao; Yu Zeng; Sujuan Xu; Xuemei Jia; Pengfei Xu
Journal:  Oncotarget       Date:  2017-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.